Jefferies Financial
JEF
44.14
-0.82
-1.82%
Jefferies Financial
US · JEF
#1424 by market cap
Listed 1970
44.14
-0.82
-1.82%
Live - 5344 symbols - heartbeat 271s ago
· 2026-10-08 07:00
Pre-market
44.14
0.00%
After-hours
44.29
+0.34%
Overnight
43.84
-0.68%
- Market cap
- 10.14B
- P/E (TTM)i
- 12.13
- P/Bi
- 0.96
- EPSi
- 2.83
- Div yieldi
- 3.62%
- 52W posi
- 30%
Reader sentiment
Are you bullish or bearish on JEF?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Weak
- Altman Z-Score is 1.00, below the 1.8 "distress zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +2.93% YoY
Margins
- Gross margin
- 58.05%
- Operating margin
- 42.79%
- Net margin
- 5.83%
Key ratios & quality
- Enterprise valuei
- 19.26B
- Altman Z-Scorei
- 1.00
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 3.76B | 3.89B | 6.01B | 8.95B | 7.15B | 7.44B | 10.52B | 10.82B |
| Gross profit | 2.57B | 2.90B | 3.33B | 4.62B | 3.77B | 4.51B | 6.22B | 6.28B |
| Selling & admin expenses | 961.33M | 1.01B | 1.08B | 710.15M | 792.99M | 849.53M | 961.47M | 1.04B |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 1.48B | 1.74B | 2.09B | 3.52B | 2.61B | 3.31B | 4.71B | 4.63B |
| Pretax profit | 296.10M | 478.61M | 1.07B | 2.25B | 1.06B | 354.27M | 1.01B | 870.99M |
| Tax | 19.01M | -483.96M | 298.67M | 576.73M | 273.85M | 91.88M | 293.19M | 184.57M |
| Net profit | 1.05B | 962.56M | 768.41M | 1.68B | 781.71M | 262.39M | 716.02M | 682.05M |
| Basic EPS | 3 | 3 | 3 | 6 | 3 | 1 | 3 | 3 |
| Diluted EPS | 2.90 | 3.03 | 2.65 | 6.13 | 3.06 | 1.10 | 2.99 | 2.83 |
| Line item | 2025-05 | 2025-08 | 2025-11 | 2026-02 | 2026-05 | 2026-08 |
|---|---|---|---|---|---|---|
| Revenue | 1.63B | 2.05B | 5.55B | 2.87B | 2.21B | 2.22B |
| Gross profit | 1.47B | 1.67B | 1.67B | 1.62B | 1.75B | 1.88B |
| Selling & admin expenses | 254.68M | 263.41M | 278.20M | 270.66M | 296.07M | 296.60M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 1.07B | 1.25B | 1.20B | 1.19B | 1.29B | 1.42B |
| Pretax profit | 134.90M | 331.82M | 253.21M | 212.22M | 315.55M | 351.04M |
| Tax | 43.51M | 89.31M | 37.54M | 52.87M | 65.57M | 86.98M |
| Net profit | 91.40M | 242.50M | 211.30M | 159.35M | 249.98M | 264.06M |
| Basic EPS | 0 | 1 | 1 | 1 | 1 | 1 |
| Diluted EPS | 0.40 | 1.01 | 0.85 | 0.70 | 1.02 | 1.13 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 33.54B | 15.88B | 17.96B | 30.74B | 30.91B | 34.85B | 39.61B | 43.26B |
| Cash & ST investments | 24.13B | 7.68B | 9.06B | 10.76B | 9.70B | 8.53B | 12.15B | 14.04B |
| Inventory | -- | -- | -- | -- | -- | -- | -- | -- |
| Total assets | 47.13B | 49.46B | 53.12B | 56.11B | 51.06B | 57.91B | 64.36B | 76.01B |
| Total current liabilities | 25.92B | 16.23B | 19.47B | 11.97B | 9.31B | 12.41B | 11.71B | 17.78B |
| Short-term debt | 9.03B | 8.05B | 9.08B | 221.86M | 528.39M | 989.72M | 443.16M | 1.77B |
| Long-term debt | 9.46B | 9.86B | 10.16B | 10.65B | 12.66B | 14.56B | 19.29B | 21.40B |
| Total liabilities | 37,032,059,000.00 | 39,831,945,000.00 | 43,655,151,000.00 | 45,502,271,000.00 | 40,755,743,000.00 | 48,102,620,000.00 | 54,134,916,000.00 | 65,369,738,000.00 |
| Total equity | 10.10B | 9.63B | 9.46B | 10.61B | 10.30B | 9.80B | 10.23B | 10.64B |
| Retained earnings | 5.61B | 5.93B | 6.53B | 7.94B | 8.42B | 7.85B | 8.27B | 8.57B |
| Line item | 2025-05 | 2025-08 | 2025-11 | 2026-02 | 2026-05 | 2026-08 |
|---|---|---|---|---|---|---|
| Total current assets | 39.04B | 39.39B | 43.26B | 43.22B | 42.04B | -- |
| Cash & ST investments | 11.26B | 11.46B | 14.04B | 11.96B | 14.31B | -- |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | 67.29B | 69.32B | 76.01B | 74.38B | 79.54B | -- |
| Total current liabilities | 12.17B | 12.52B | 17.78B | 15.71B | 18.75B | -- |
| Short-term debt | 1.32B | 1.23B | 1.77B | 1.92B | 1.60B | -- |
| Long-term debt | 21.02B | 21.86B | 21.40B | 23.38B | 24.32B | -- |
| Total liabilities | 56,902,764,000.00 | 58,818,393,000.00 | 65,369,738,000.00 | 63,718,356,000.00 | 68,932,155,000.00 | -- |
| Total equity | 10.38B | 10.50B | 10.64B | 10.66B | 10.61B | -- |
| Retained earnings | 8.31B | 8.46B | 8.57B | 8.65B | 8.80B | -- |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 691.10M | -827.84M | 2.08B | 1.58B | 1.80B | -1.93B | -209.26M | -1.50B |
| Depreciation & amortization | 67.41M | 129.77M | 142.39M | 144.26M | 189.34M | 113.47M | 197.85M | 201.91M |
| Free cash flow | 365.44M | -1.06B | 1.90B | 1.42B | 1.58B | -1.93B | -459.84M | -1.71B |
| Dividends paid | -151.76M | -149.65M | -160.94M | -222.80M | -280.10M | -278.60M | -302.96M | -374.13M |
| Stock buybacks / issuance | -1.13B | -509.91M | -816.87M | -269.40M | -859.59M | -169.40M | -44.31M | -58.52M |
| Ending cash balance | 6.01B | 8.48B | 9.66B | 11.83B | 10.71B | 9.83B | 13.17B | 14.96B |
| Line item | 2025-05 | 2025-08 | 2025-11 | 2026-02 | 2026-05 | 2026-08 |
|---|---|---|---|---|---|---|
| Operating cash flow | -978.33M | 184.19M | 1.96B | -1.74B | 1.60B | -- |
| Depreciation & amortization | 55.46M | 55.98M | 57.47M | 41.34M | 40.97M | -- |
| Free cash flow | -1.02B | 126.01M | 1.90B | -1.80B | 1.55B | -- |
| Dividends paid | -94.32M | -93.54M | -93.54M | -92.79M | -91.81M | -- |
| Stock buybacks / issuance | -1.25M | -918.00K | -29.00K | -174.30M | -197.41M | -- |
| Ending cash balance | 12.31B | 12.57B | 14.96B | 13.72B | 15.45B | -- |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | -- | 9.71 | 8.06 | 16.61 | 7.45 | 2.49 | 6.74 | 6.09 |
| ROA %i | -- | 1.98 | 1.49 | 2.92 | 1.39 | 0.46 | 1.09 | 0.90 |
| ROIC %i | -- | 7.22 | 5.10 | 7.69 | 6.33 | 9.65 | 11.13 | 10.40 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | 8.90 | 8.30 | 7.91 |
| EBIT margin %i | -- | 36.28 | 28.93 | 34.39 | 31.14 | 41.60 | 42.66 | 40.20 |
| FCF / sales %i | -- | -- | 27.30 | 15.57 | 22.11 | -- | -- | -- |
| Current ratioi | -- | 0.98 | 0.92 | 2.57 | 3.32 | 2.81 | 3.38 | 2.43 |
| Quick ratioi | -- | 0.93 | 0.89 | 1.42 | 1.58 | 1.17 | 1.65 | 1.36 |
| Debt / assetsi | -- | 36.22 | 37.33 | 20.36 | 26.88 | 27.79 | 31.64 | 31.25 |
| LT debt / equityi | -- | 102.95 | 114.29 | 106.12 | 128.95 | 155.54 | 196.14 | 207.95 |
| Interest coveragei | -- | 1.33 | 2.13 | 3.64 | 1.90 | 1.13 | 1.29 | 1.25 |
| Revenue CAGR (3Y) %i | -- | -18.04 | 16.31 | 15.72 | 10.09 | 2.27 | 5.54 | 14.83 |
| Net income CAGR (3Y) %i | -- | 36.68 | 57.74 | 78.83 | -6.62 | -28.98 | -23.71 | -3.29 |
| FCF CAGR (3Y) %i | -- | -- | 58.08 | 21.28 | -- | -- | -- | -- |
| Line item | 2025-05 | 2025-08 | 2025-11 | 2026-02 | 2026-05 | 2026-08 |
|---|---|---|---|---|---|---|
| ROE %i | 5.85 | 6.31 | 6.09 | 6.33 | 7.64 | -- |
| ROA %i | 0.91 | 0.98 | 0.90 | 0.91 | 1.09 | -- |
| ROIC %i | 10.12 | 9.93 | 10.40 | 9.35 | 10.04 | -- |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 42.15 | 41.18 | 40.20 | 39.09 | 38.99 | 39.34 |
| FCF / sales %i | -- | -- | -- | -- | 15.02 | -- |
| Current ratioi | 3.21 | 3.15 | 2.43 | 2.75 | 2.24 | -- |
| Quick ratioi | 1.56 | 1.56 | 1.36 | 1.40 | 1.29 | -- |
| Debt / assetsi | 34.11 | 34.18 | 31.25 | 34.78 | 33.29 | -- |
| LT debt / equityi | 209.93 | 215.20 | 207.95 | 225.76 | 235.39 | -- |
| Interest coveragei | 1.24 | 1.26 | 1.25 | 1.27 | 1.32 | 1.31 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Single-engine
- Investment Banking and Capital Markets is the largest reported line at 89.56% of revenue, across 3 reported segments.
- The next-largest line, Asset Management, is a distant second at 10.41% - a sharp slowdown here would have little to offset it.
Revenue breakdown most recent period
Business
Investment Banking and Capital Markets89.56%
Asset Management10.41%
Quote time 2026-10-08 07:00:07 · For reference only, not investment advice and not tailored to your situation.